S6 Ep9: Ku Reviews Exciting ESMO Data in Gastric/GEJ Cancer

Dr. Ku underscores key takeaways from the CheckMate649 and DESTINY-Gastric02 trials in gastric/GEJ cancer and highlights ongoing research that has the potential to further inform treatment selection and sequencing in the field